Taiwan Resonant Waves Research

Taiwan Resonant Waves Research has developed a non-invasive wearable bioelectronic stimulator targeting chronic diseases such as type 2 and type 1 diabetes, insomnia, obstructive sleep apnea, inflammatory bowel disease, and pain. The company’s lead program for type 2 diabetes has completed a pivotal clinical trial that passed GCP inspection by the Taiwan FDA. Their pain-relief nerve stimulator received class II medical device approval in Taiwan. Pilot and feasibility studies have been conducted for various sleep disorder indications. Ongoing research includes expanded applications in metabolic diseases and inflammatory conditions. The company collaborates with international partners on regulatory strategy for US/EU markets.[1]